Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.

ABSTRACT:

SUBMITTER: Loncharich MF 

PROVIDER: S-EPMC9190216 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature